QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITORS - HETEROCYCLIC BENZOYL RING MODIFICATIONS

被引:102
作者
MARSHAM, PR [1 ]
HUGHES, LR [1 ]
JACKMAN, AL [1 ]
HAYTER, AJ [1 ]
OLDFIELD, J [1 ]
WARDLEWORTH, JM [1 ]
BISHOP, JAM [1 ]
OCONNOR, BM [1 ]
CALVERT, AH [1 ]
机构
[1] INST CANC RES, SUTTON SM2 5NG, SURREY, ENGLAND
关键词
D O I
10.1021/jm00109a011
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis is described of a series of C2-methyl-N10-alkylquinazoline-based antifolates in which the p-aminobenzoate ring is replaced by the heterocycles thiophene, thiazole, thiadiazole, pyridine, and pyrimidine. These were generally elaborated by the reaction of (bromomethyl)quinazoline 18 or its N3-[(pivaloyloxy)methyl]-protected derivative 36 with suitable heterocyclic amines although each heterocyclic system required its own particular synthetic approach. The compounds were tested as inhibitors of partially purified L1210 thymidylate synthase (TS). They were also examined for their inhibition of the growth of L1210 cells in culture. The thiophene system 7 and its related thiazole 8 gave analogues that were considerably more potent than the parent benzene series 2 as inhibitors of L1210 cell growth although in general these heterocycles were somewhat poorer inhibitors of the isolated TS enzyme. The enhanced cytotoxicities of the thiophene and thiazole analogues result, at least in part, from their efficient transport into the cells via the reduced folate carrier mechanism and very good substrate activity for folylpolyglutamate synthetase. The replacement of the C2-methyl group by C2-(fluoromethyl) and C2-(hydroxymethyl) substituents in the thiophene and thiazole series gave derivatives that were only slightly less potent inhibitors of the TS enzyme but which were considerably less cytotoxic.
引用
收藏
页码:1594 / 1605
页数:12
相关论文
共 34 条
  • [1] STRUCTURE OF THIOPHENE
    BAK, B
    CHRISTENSEN, D
    HANSENNYGAARD, L
    RASTRUPANDERSEN, J
    [J]. JOURNAL OF MOLECULAR SPECTROSCOPY, 1961, 7 (01) : 58 - &
  • [2] INDUCTION OF REMISSION IN HEPATOCELLULAR-CARCINOMA WITH A NEW THYMIDYLATE SYNTHASE INHIBITOR, CB3717 - A PHASE-II STUDY
    BASSENDINE, MF
    CURTIN, NJ
    LOOSE, H
    HARRIS, AL
    JAMES, OFW
    [J]. JOURNAL OF HEPATOLOGY, 1987, 4 (03) : 349 - 356
  • [3] BISSET GMF, 1990, P AM ASSOC CANC RES, V31, P342
  • [4] A PHASE-I EVALUATION OF THE QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR, N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID, CB3717
    CALVERT, AH
    ALISON, DL
    HARLAND, SJ
    ROBINSON, BA
    JACKMAN, AL
    JONES, TR
    NEWELL, DR
    SIDDIK, ZH
    WILTSHAW, E
    MCELWAIN, TJ
    SMITH, IE
    HARRAP, KR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (08) : 1245 - 1252
  • [5] CALVERT AH, 1987, NATL CANCER I MONOGR, V5, P21
  • [6] DORNOW A, 1953, Arch Pharm Ber Dtsch Pharm Ges, V286, P494, DOI 10.1002/ardp.19532861006
  • [7] GURINA SL, 1977, BIOORG KHIM+, V3, P1133
  • [8] HANSENNYGAARD L, 1971, J MOL STRUCT, V9, P222
  • [9] HETEROCYCLIC DYES AND PRELIMINARY STEPS .17. SYNTHESIS AND CHARACTERIZATION OF 1,1-DISUBSTITUTED THIOUREAS
    HARTMANN, H
    REUTHER, I
    [J]. JOURNAL FUR PRAKTISCHE CHEMIE, 1973, 315 (01): : 144 - 148
  • [10] QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITORS - ALKYL, SUBSTITUTED ALKYL, AND ARYL SUBSTITUENTS IN THE C2 POSITION
    HUGHES, LR
    JACKMAN, AL
    OLDFIELD, J
    SMITH, RC
    BURROWS, KD
    MARSHAM, PR
    BISHOP, JAM
    JONES, TR
    OCONNOR, BM
    CALVERT, AH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (11) : 3060 - 3067